Not applicableStudy completedNCT02824640What this trial is testingPatient-Centered Models of HCV Care for People Who Inject DrugsWho this might be right forHepatitis CMedication Adherence Prisma Health-Upstate 755
Not applicableStudy completedNCT03127358What this trial is testingSmartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDsWho this might be right forHepatitis CMedication Adherence Albert Einstein College of Medicine 11
Large-scale testing (Phase 3)Study completedNCT00002220What this trial is testingIndinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With NelfinavirWho this might be right forHIV Infections Merck Sharp & Dohme LLC 120
Early research (Phase 1)Study completedNCT01181427What this trial is testingStudy of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected SubjectsWho this might be right forHCV Infection Abbott 137
Not applicableLooking for participantsNCT04098315What this trial is testingItalian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.Who this might be right forHIV-1-infectionMulti-Antiviral Resistance Castagna Antonella 300
Large-scale testing (Phase 3)Study completedNCT02792088What this trial is testingStudy to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside AnaloguesWho this might be right forChronic Hepatitis B IlDong Pharmaceutical Co Ltd 146
Testing effectiveness (Phase 2)Study completedNCT00964327What this trial is testingTMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) StrainsWho this might be right forHIV Infections Tibotec Pharmaceuticals, Ireland 42
Testing effectiveness (Phase 2)Study completedNCT00895596What this trial is testingSafety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis BWho this might be right forChronic Hepatitis B LG Life Sciences 65
Not applicableStudy completedNCT05388474What this trial is testingA Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without IbalizumabWho this might be right forHIV InfectionsMulti-Antiviral Resistance Theratechnologies 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04648280What this trial is testingSafety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral ResistanceWho this might be right forHIV Infections With Multi Drug Resistant Virus PENTA Foundation 60
Post-approval studies (Phase 4)UnknownNCT01594905What this trial is testingEntecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus InfectionWho this might be right forChronic Hepatitis B Yonsei University 90
Testing effectiveness (Phase 2)UnknownNCT00299897What this trial is testingSP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV PatientsWho this might be right forHIV InfectionsHuman Immunodeficiency Virus Samaritan Pharmaceuticals, Inc 60
Early research (Phase 1)Study completedNCT01473056What this trial is testingStudy to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected SubjectsWho this might be right forHepatitis C Virus Infection, Response to Therapy of Akros Pharma Inc. 29
Testing effectiveness (Phase 2)Looking for participantsNCT07670468What this trial is testingEvaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.Who this might be right forBKV InfectionEBV InfectionCMV Infection LucasBio 27